You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 110 No. 4, April 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  LABORATORY SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Tangential Corneal Surface Ablation With 193- and 308-nm Excimer and 2936-nm Erbium-YAG Laser Irradiation

Barry M. Belgorod, MD; Marwood N. Ediger, PhD; Richard P. Weiblinger, MA; Robert A. Erlandson, PhD

Arch Ophthalmol. 1992;110(4):533-536.


Abstract

• An argon-fluoride excimer laser operating at 193 nm was used to perform tangential, wide-area surface photoablation of the corneas of bovine eyes. Comparisons were made with similar tangential ablations performed with the use of 308-nm xenon chloride excimer laser and qi/gl 2936-nm erbium-YAG laser irradiation to evaluate potential photochemical and thermal effects. Light and transmission electron microscopy of the corneal tissue revealed minimal tissue architectural changes for ablation at 193 nm. The zone of ultrastructural change at the corneal surface with the 193-nm excimer laser was 120 nm thick. The clinical appearance of the corneal surfaces produced by the tangential ablation at 193 nm was the most satisfactory of those with the three wavelengths tested, being macroscopically smooth and glossy.



Author Affiliations

From the Departments of Ophthalmology, Manhattan Eye, Ear, and Throat Hospital and New York Hospital-Cornell University Medical Center, New York, NY (Dr Belgorod); US Food and Drug Administration, Center for Devices and Radiological Health, Rockville, Md (Dr Ediger and Mr Weiblinger); and Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York (Dr Erlandson).


Footnotes

Accepted for publication October 8, 1991.

This is not an official report of the US Food and Drug Administration. The opinions and statements contained in this article are those of the authors and may not reflect the views of the US Food and Drug Administration.

Reprint requests to 115 E 61 St, New York, NY. 10021 (Dr Bolgorod).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.